Pubblicazioni - Fondazione IRCCS

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI - MILANO
S.C. EPIDEMIOLOGIA ANALITICA E IMPATTO SANITARIO
ELENCO PUBBLICAZIONI (aggiornate novembre 2016)
1. Sebastiani F, Cortesi L, Sant M, Lucarini V, Cirilli C, De Matteis E, Marchi I, Negri R, Gallo E,
Federico M.Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass
Index at the Modena Screening Program. J Breast Cancer. 2016;19(3):283-291.
2. Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V. A novel
approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly
women. Breast Cancer Res Treat. 2016;158(3):553-61
3. De Santis MC, Bonfantini F, Di Salvo F, Dispinzieri M, Mantero E, Soncini F, Baili P, Sant M,
Bianchi G, Maggi C, Di Cosimo S, Agresti R, Pignoli E, Valdagni R, Lozza L Factors influencing
acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. Breast. 2016 Jul
28;29:90-95.
4. Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johansson U,
Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de
Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Mátrai Z, Sávolt Á, Nagy P, Kásler M,
Schrotz-King P, Ulrich C, Brenner H Time trends in axilla management among early breast cancer
patients: Persisting major variation in clinical practice across European centers. Acta Oncol. 2016
Jun;55(6):712-9.
5. Baili P, Di Salvo F, de Lorenzo F, Maietta F, Pinto C, Rizzotto V, Vicentini M, Giorgi Rossi P,
Tumino R, Rollo PC, Tagliabue G, Contiero P, Candela P, Scuderi T, Iannelli E, Cascinu S, Aurora
F, Agresti R, Turco A, Sant M, Meneghini E, Micheli A.Out-of-pocket costs for cancer survivors
between 5 and 10 years from diagnosis: an Italian population-based study. Support Care Cancer.
2016;24(5):2225-33.
6. Agresti R, Meneghini E, Baili P, Minicozzi P, Turco A, Cavallo I, Funaro F, Amash H, Berrino
F, Tagliabue E, Sant M. Association of adiposity, dysmetabolisms, and inflammation with
aggressive breast cancer subtypes: a cross-sectional study. Breast Cancer Res Treat. 2016
;157(1):179-89
7. De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié
M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE5 Working Group. Survival variations by country and age for lymphoid and myeloid malignancies in
Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer 2015; pii:
S0959-8049(15)00778-9.
8. Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, Knijn A, Pastorino
U, Salmerón D, Trama A, Sant M; EUROCARE-5 Working Group. Survival patterns in lung and
pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer 2015;5.
pii: S0959-8049(15)00713-3.
9. Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group.
Survivalof adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5
study. Eur J Cancer. 2015; pii: S0959-8049(15)00712-1
10. Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M;
EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: Results of the
population-based studyEUROCARE-5. Eur J Cancer. 2015; pii: S0959-8049(15)00708-X
11. Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L,
NicolaiN; EUROCARE-5 Working Group. Survival of male genital cancers (prostate, testis and
penis) in Europe1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. 2015; pii: S09598049(15)00708-X
12. Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M,
Dimitrova N,Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P;
EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in
Europe 1999-2007: results of theEUROCARE-5 study. Eur J Cancer. 2015; pii: S09598049(15)00702-9.
13. Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A,
Faivre J;EUROCARE-5 Working Grouph. Survival in patients with primary liver cancer, gallbladder
andextrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of
EUROCARE-5. EurJ Cancer. 2015;5 pii: S0959-8049(15)00714-5
14. Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT,
CookMB, Bannon F, Sant M; EUROCARE-5 Working Group. Survival for oesophageal, stomach
and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur J Cancer. 2015 ;
5. pii: S0959-8049
15. Sant M, Minicozzi P, Primic-Žakelj M, Otter R, Francisci S, Gatta G, Berrino F, De Angelis R.
Cancer survival in Europe, 2000-2007: Doing better, feeling worse? Eur J Cancer. 2015 ;4. pii:
S0959-8049(15)00809-6
16. Di Salvo F, Meneghini E, Vieira V, Baili P, Mariottini M, Baldini M, Micheli A, Sant M. Spatial
variationin mortality risk for hematological malignancies near a petrochemical refinery: A
population-based casecontrolstudy. Environ Res. 2015;140:641-8
17. Baili P, Torresani M, Agresti R, Rosito G, Daidone MG, Veneroni S, Cavallo I, Funaro F, Giunco
M,Turco A, Amash H, Scavo A, Minicozzi P, Bella F, Meneghini E, Sant M. A breast cancer
clinical registryin an Italian comprehensive cancer center: an instrument for descriptive, clinical, and
experimental research.Tumori. 2015:;101(4):440-6
18. Tumino R, Minicozzi P, Frasca G, Allemani C, Crocetti E, Ferretti S, Giacomin A, Natali M,
Mangone L,Falcini F, Capocaccia R, Sant M. Population-based method for investigating adherence
to internationalrecommendations for pathology reporting of primary cutaneous melanoma: Results of
a EUROCARE-5 highresolution study. Cancer Epidemiol. 2015;39(3):424-9
19. Micheli A, Meneghini E, Mariottini M, Baldini M, Baili P, Di Salvo F, Sant M. Risk of death for
hematological malignancies for residents close to an Italian petrochemical refinery: a populationbased casecontrol study. Cancer Causes Control. 2014;25(12):1635-44
20. Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R,
Maynadié M,Monnereau A, Osca-Gelis G, Visser O, De Angelis R; EUROCARE-5 Working Group.
Survival forhaematological malignancies in Europe between 1997 and 2008 by region and age:
results of EUROCARE-5, a population-based study. Lancet Oncol. 2014;15(9):931-42
21. Minicozzi P, Bouvier AM, Faivre J, Sant M; Study working group. Management of rectal cancers
inrelation to treatment guidelines: a population-based study comparing Italian and French patients.
Dig LiverDis. 2014;46(7):645-51
22. Di Salvo F, Baili P, Vicentini M, Tumino R, Vercelli M, Pirino D, Contiero P, Foschi R, Minicozzi
P,Giorgi Rossi P, De Lorenzo F, Micheli A; CAREMORE Group. Cancer rehabilitation services: an
Italianpopulation-based cohort study. Tumori. 2014;100(3):346-51
23. Minicozzi P, Kaleci S, Maffei S, Allemani C, Giacomin A, Caldarella A, Iachetta F, Fusco M,
Tumino R,Vicentini M, Falcini F, Cesaraccio R, Ponz de Leon M, Sant M. Disease presentation,
treatment and survivalfor Italian colorectal cancer patients: a EUROCARE high resolution study.
Eur J Public Health.2014;24(1):98-100
24. European Partnership Action Against Cancer consensus group, Borras JM, Albreht T, Audisio R,
Briers E,Casali P, Esperou H, Grube B, Hamoir M, Henning G, Kelly J, Knox S, Nabal M, Pierotti
M, Lombardo C,van Harten W, Poston G, Prades J, Sant M, Travado L, Valentini V, van de Velde
C, van den Bogaert S, vanden Bulcke M, van Hoof E, van den Neucker I, Wilson R. Policy
statement on multidisciplinary cancer care.Eur J Cancer. 2014;50(3):475-80
25. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch
P, LacourB, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani
M, Stiller C,Tavilla A, Trama A, Visser O, Peris-Bonet R; EUROCARE Working Group. Childhood
cancer survival inEurope 1999-2007: results of EUROCARE-5-a population-based study. Lancet
Oncol. 2014;15(1):35-47. Erratum in: Lancet Oncol. 2014;15(2):e52
26. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O,
Brenner H,Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F,
Capocaccia R; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country
and age: results of EUROCARE--5-apopulation-based study. Lancet Oncol. 2014;15(1):23-34
27. Minicozzi P, Berrino F, Sebastiani F , Falcini F , Vattiato R, Cioccoloni F, Calegreti G, Fusco M,
Vitale MF,Tumino R, Sigona A, Budroni M, Cesaraccio R, Candela G, Scuderi T, Zarcone M,
Campisi I, Sant M. Highfasting blood glucose and obesity significantly and independently increase
risk of breast cancer death inhormone receptor-positive disease. Eur J Cancer. 2013;49(18):3881-8
28. Minicozzi P, Bella F, Toss A, Giacomin A, Fusco M, Zarcone M, Tumino R, Falcini F, Cesaraccio
R,Candela G, La Rosa F, Federico M, Sant M. Relative and disease-free survival for breast cancer in
relationto subtype: a population-based study. J Cancer Res Clin Oncol. 2013;139(9):1569-77
29. Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, Ponz de Leon M, Fusco M, Tumino R,
Mangone L, Giuliani O, Budroni M, Sant M. Impact of diabetes on overall and cancer-specific
mortality in colorectalcancer patients. J Cancer Res Clin Oncol. 2013;139(8):1303-10
30. Bouvier AM, Minicozzi P, Grosclaude P, Bouvier V, Faivre J, Sant M. Patterns of adjuvant
chemotherapy for stage II and III colon cancer in France and Italy. Dig Liver Dis. 2013;45(8):687-91
31. Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R; EUROCARE Working
Group. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol.
2013;24(6):1660-6
32. Mangone L, Minicozzi P, Vicentini M, Giacomin A, Caldarella A, Cirilli C, Falcini F, Giorgi Rossi
P, Sant M. Key factors influencing lung cancer survival in northern Italy. Cancer Epidemiol 2013
;37(3):22633. Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J,Ameijide A, Siesling S,
Mangone L, Ardanaz E, Hédelin G, Mateos A, Micheli A, Sant M; EUROCARE Working Group.
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in
2000-2002. Int J Cancer. 2013;15;132(10):2404-12.
34. Gatta G, Rossi S, Foschi R, Trama A, Marcos-Gragera R, Pastore G, Peris-Bonet R, Stiller C,
Capocaccia R;EUROCARE Working Group. Survival and cure trends for European children,
adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.
Haematologica. 2013;98(5):744-52
35. Tereanu C; Baili P; Berrino F; Micheli A; Furtunescu FL; Minca DG; Sant M. Recent trends of
cancermortality in Romanian adults: mortality is still increasing; although young adults do better
than the middle-aged and elderly population. 2013;22(3):199-209
36. Allemani C, Sant M, Weir HK, Richardson LC,Baili P; Storm H,et al.. Breast cancer survival in the
US andEurope: A CONCORD high-resolution study. Int J Cancer. 2013;1;132(5)
37. Maynadie' M; De Angelis R; Marcos-Gragera R; Visser O; Allemani C; Tereanu C; Capocaccia R;
Giacomin A; Lutz JM; Martos C; Sankila R; Børge Johannesen T; Simonetti A; Sant M. Survival of
European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica.
2013;98(2):230-8
38. Baili P, Vicentini M, Tumino R, Vercelli M, Lorenzo M, Foschi R, Guzzinati S, Dal Maso L,
Minicozzi P,de Lorenzo F, Micheli A, Di Salvo F; The Caremore Group. A method for
differentiating cancer prevalence according to health status, exemplified using a population-based
sample of Italian colorectal cancer cases.Acta Oncol. 2013;52(2):294-302
39. Ajayi OA, Sant M, Ikhena S, Bako A. Uterine rupture complicating sequential curettage and Bakri
balloontamponade to control secondary PPH. BMJ Case Rep. 2013; 6;2013
40. Cortesi L, Marcheselli L, Guarneri V, Cirilli C, Braghiroli B, Toss A, Sant M, Ficarra G, Conte PF,
FedericoM. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong
value in patientswith operable breast cancer diagnosed in recent years. Int J Cancer. 2013;
15;132(2):E58-65
41. Siesling S, Kwast A, Gavin A, Baili P, Otter R; EUROCHIP-3 Workpackage 5. Availability of stage
at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry
indicators forcancer care in Europe: Results of EUROCHIP-3 survey. Int J Cancer 2013
15;132(12):2910-7
42. Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M, Di Salvo F, Micheli
A,Veerus P; The EUROCHIP-3 Working group on Cancer Rehabilitation. Cancer rehabilitation
indicators for Europe. Eur J Cancer. 2013;49(6):1356-64
43. Minicozzi P, Caldarella A, Giacomin A, Ponz de Leon M, Cesaraccio R, Falcini F, Fusco M,
Iachetta F,Pellegri C, Tumino R, Capocaccia R, Sant M. Looking at differences in stage and
treatment of colorectal cancers across Italy: a EUROCARE-5 High Resolution study. Tumori
2012;98(6):671-677
44. Sant M,Minicozzi P, Allemani C, Cirilli C,Federico M,Capocaccia R,Budroni M,Candela P,Crocetti
E, Falcini F, Ferretti F, Fusco M, Giacomin A,La Rosa F,Mangone L,Natali M,Ponz De Leon
M,Traina A,Tumino R, Zambon R. Regional inequalities in cancer care persist in Italy and can
influence survival. Cancer Epidemiol. 2012;36(6):541-7
45. Lhachimi SK, Cole KJ, Nusselder WJ, Smit HA, Baili P, Bennett K, Pomerleau J,McKee M,
Charlesworth K, Kulik MC, Mackenbach JP, Boshuizen H. Health impacts of increasing alcohol
prices in the European Union: a dynamic projection. Prev Med 2012;55(3):237-43
46. Sant M, Minicozzi P, Lagorio S, Børge Johannesen T,Marcos-Gragera R, Francisci S; the
EUROCARE Working Group. Survival of European patients with central nervous system tumors. Int
J Cancer. 2012;1;131(1):173-185
47. Minicozzi P, Cirilli C,Federico M,Capocaccia R,Budroni M,Candela P, Falcini F, Fusco M,
Giacomin A,La Rosa F,Traina A,Tumino , Sant M. Differences in stage and treatment of breast
cancer across Italy point to inequalities in access to and availability of proper care. Tumori. 2012
;98(2).204-9
48. Oberaigner W; Minicozzi P; Bielska-Lasota M; Allemani C; De Angelis R; Mangone L; Sant M;
theEUROCARE Working Group. Survival for Ovarian Cancer in Europe: The across-country
variation did not shrink in the past decade. Acta Oncologica 2012;51(4).441-53
49. Kulik MC; Nusselder WJ; Boshuizen HC; Lhachimi SK; Fernández E; Baili P; et al. Comparison of
tobacco control scenarios: quantifying estimates of long-term health impact using the DYNAMOHIA modeling tool. PLoS One. 2012;7(2):e32363.
50. Lhachimi SK; Nusselder WJ; Smit HA; van Baal P; Baili P; et al. DYNAMO-HIA-A Dynamic
Modeling Tool for Generic Health Impact Assessments. PLoS One. 2012;7(5):e33317.
51. Marcos-Gragera R; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Maynadie M; Luminari
S; et al.Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of
the HAEMACARE project. Haematologica 2011; 96(5):720-8
52. Zigon G, Berrino F, Gatta G, Sánchez MJ, van Dijk B, Van Eycken E, Francisci S; EUROCARE
Working Group. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999. a
population-based study.Ann Oncol. 2011;22(1).165-74
53. Micheli A, Di Salvo F, Lombardo C, Ugolini D, Baili P, Pierotti M.A.: Cancer research
performance in the European Union: a study of published output from 2000 to 2008. Tumori 2011;
97(6): 683-689
54. Allemani C, Berrino F, Krogh V, Sieri S, Pupa S.M, Tagliabue E, Tagliabue G, Sant M.
Do pre-diagnostic drinking habits influence breast cancer survival? Tumori 2011; 97(2):142-148
55. Kivistik A, Lang K, Baili P, Anttila A, Veerus P.: Women's knowledge about cervical cancer risk
factors; screening; and reasons for non-participation in cervical cancer screening programme in
Estonia. BMC Womens Health 2011;2851.
56. Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M,
Fabricio A.S.C, Berrino F, Cavalleri A, Micheli A. Circulating sex hormones and tumor
characteristics in postmenopausal breast cancer patients. A cross-sectional study. Int J Biol Markers
2011; 26: 241-246
57. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R,
Simonetti A, the HAEMACARE Working Group; et al. Incidence of hematologic malignancies in
Europe by morphologic subtype: results of HAEMACARE project. Blood 2010; 11;116(19):3724-34
58. HAEMACARE Working Group. Manual for coding and reporting haematological malignancies.
Tumori 2010;96(4):i-A32.
59. Anttila A, Arbyn M, Veerus P, Viberga I, Kurtinaitiene R, Valerianova Z, Apostol I, Baili P,
Micheli A. Barriers in cervical cancer screening programs in new European Union member states.
Tumori 2010;96(4):515-516
60. Arbyn M, Antoine J, Valerianova Z, Magi M, Stengrevics A, Smailyte G, Suteu O, Micheli A.:
Trends incervical cancer incidence and mortality in Bulgaria; Estonia; Latvia; Lithuania and
Romania. Tumori 2010; 96(4): 517-523
61. Valerianova Z, Panayotova Y, Amati C, Baili P; EUROCHIP Working Group. Cervical cancer
screeningin Bulgaria--past and present experience. Tumori. 2010;96(4):538-44.
62. Viberga I, Engele L, Baili P; EUROCHIP Working Group. Past, present and future of the cervical
cancer screening in Latvia. Tumori. 2010;96(4):529-37.
63. Veerus P, Arbyn M, Amati C, Baili P, on behalf of the EUROCHIP Working Group. Impact of
implementing a nationwide cervical cancer screening program on female population coverage by
Pap-tests in Estonia. Tumori 2010;96(4): 524-528
64. Apostol I, Baban A, Nicula F, Suteu O, Coza D, Amati C, Baili P; EUROCHIP Working Group.
Cervical cancer assessment in Romania under EUROCHIP-2. Tumori. 2010;96(4):545-52.
65. Veerus P, Arbyn M, Amati C, Paolo B; EUROCHIP Working Group. Impact of implementing a
nationwide cervical cancer screening program on female population coverage by Pap-tests in
Estonia.Tumori. 2010;96(4):524-8.
66. Marcos-Gragera R, Cervantes-Amat M, Vicente M.L, de Sanjose S, Guallar E, Godoy C, Calvo C,
Giraldo P,Sant M, Peris-Bonet R, Martos M.C. Population-based incidence of childhood leukaemias
and lymphomas in Spain (1993-2002). Eur J Cancer Prev 2010 ; 19. 247-255
67. Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G; EUROCARE working
group.European disparities in malignant digestive endocrine tumours survival. Int J Cancer 2010
;15; 126.2928-2934
68. Lepage C, Sant M, Verdecchia A, Forman D, Esteve J, Faivre J, and the EUROCARE working
group.Operative mortality after gastric cancer resection and long-term survival differences across
Europe. Br J Surg 2010;97(2):235-9
69. Allemani C, Storm H, Voogd A.C, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M,
Aareleid T,Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P,
Hédelin G, Martinez-Garcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G,
Tumino R, Traina A,Tryggvadottir L, Vercelli M, Sant M. Variation in 'standard care' for breast
cancer across Europe. aEUROCARE-3 high resolution study. Eur J Cancer 2010;46(9):1528-36
70. Bouvier A.M, Sant M, Verdecchia A, Forman D, Damhuis R, Coebergh J.W, Crocetti E, Crosignani
P, GafaL, Launoy G, Martinez-Garcia C, Plesko I, Pompe-Kirn V, Rachtan J, Velten M, Vercelli M,
Zwierko M,Esteve J, Faivre J. What reasons lie behind long-term survival differences for gastric
cancer within Europe?Eur J Cancer. 2010;46(6):1086-92
71. Micheli A; Baili P; Ciampichini R; Verdecchia A. Evaluating the outcomes of cancer control. In
Elwood JM; Sutcliffe AB (Ed) Cancer control. Oxford university press; New York
72. Endogenous Hormones and Breast Cancer; Collaborative Group; Key T.J, Appleby P.N, Reeves
G.K, Roddam A.W, Krogh V, Micheli A, Berrino F. Insulin-like growth factor 1 (IGF1); IGF
binding protein 3(IGFBP3); and breast cancer risk: pooled individual data analysis of 17 prospective
studies. Lancet Oncol 2010; 11:530-542
73. Schernhammer E.S, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos C.T,
Cavalleri A, Schunemann H.J, Strano S, Muti P. Urinary 6-Sulphatoxymelatonin levels and risk of
breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev
2010; 19: 729-737
74. Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M,
Aareleid T,Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P,
Hédelin G, Martinez-Garcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G,
Tumino R, Traina A,Tryggvadóttir L, Vercelli M, Sant M. Variation in 'standard care' for breast
cancer across Europe: aEUROCARE-3 high resolution study. Eur J Cancer. 2010;46(9):1528-36.
75. Berrino F, Verdecchia A, Lutz J.M, Lombardo C, Micheli A, Capocaccia R, the EUROCARE
WorkingGroup. Comparative cancer survival information in Europe. Eur J Cancer. 2009
;45(6):901-8
76. De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, the EUROCARE Working
Group, etal. The EUROCARE-4 database on cancer survival in Europe: Data standardisation;
quality control andmethods of statistical analysis. Eur J Cancer. 2009;45(6):909-30
77. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R,
StillerCA; EUROCARE Working Group. Survival of European children and young adults with
cancer diagnosed1995-2002. Eur J Cancer. 2009;45(6).992-1005.
78. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, the EUROCARE
WorkingGroup. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and
commentary. Eur J Cancer. 2009;45:931-991.
79. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, Colonna M, Grande
E, Grosclaude P, Vercelli M, the EUROCARE Working Group. The cancer survival gap between
elderlyand middle-aged patients in Europe is widening. Eur J Cancer. 2009;45:1006-1016.
80. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta
G, DeAngelis R, the EUROCARE Working Group. The advantage of women in cancer survival:
An analysis of EUROCARE-4 data. Eur J Cancer. 2009;45:1017-1027.
81. Brenner H, Francisci S, De Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Sant M, the
EUROCARE Working Group, et al. Long-term survival expectations of cancer patients in Europe
in 2000-2002. Eur J Cancer. 2009;45:1028-1041.
82 Ciccolallo L, Licitra L, Cantú G, Gatta G; EUROCARE Working Group. Survival from salivary
glands adenoid cystic carcinoma in European populations. Oral Oncol, 2009;45(8).669-74.
83 Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani
M, SantM, the EUROCARE Working Group. Survival trends in European cancer patients
diagnosed from 1988 to 1999. Eur J Cancer. 2009;45:1042-1066.
84 Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M,
Zigon G, Bray F, Janssen-Heijnen M, the EUROCARE Working Group. The cure of cancer: A
European perspective. Eur J Cancer. 2009;45:1067-1079.
85 Sieri S, Krogh V,Bolelli G,Abagnato CA, Grioni S,Pala V,Evangelista A,Allemani C,Micheli A,
Tagliabue G, Schunemann HJ,Menard S,Berrino F,Muti P. Sex hormone levels; breast cancer risk;
and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol
Biomarkers Prev.2009;18(1):169-76
86 Luciani S; Vardy L; Paci E; Adewole I; Sasco A; Calvacante T; ICCC-3 Session C Group. Cancer
prevention and population-based screening. Tumori 2009;95(5):597-609
87 Verdecchia A; Santaquilani M; Sant M. Survival for cancer patients in Europe. Ann Ist Super
Sanità.2009;45(3):315-24
88 Kerner JF; Cazap E; Yach D; Pierotti MA; Daidone MG; de Blasio P; Geary P; Schacter B; Sant M;
Habbema JD; Sankaranarayanan R; Sutcliffe C; Sutcliffe S; ICCC-3 Session D Group.
Comprehensivecancer control-research & development: knowing what we do and doing what we
know. Tumori.2009;95(5):610-22.
89 Capocaccia, R, Gavin, A, Hakulinen, T, Lutz, J. M, and Sant M. eds. Survival of Cancer Patients in
Europe 1995-2002.The EUROCARE-4 Study. Eur J Cancer 2009,45(6), 901-1094 (special issue)
90 Micheli A, Sanz N, Mwangi-Powell F, et al.;ICCC-3 Session B Group. International collaborations
in cancer control and the Third International Cancer Control Congress. Tumori. 2009;95(5):579-96
91 Harford JB,Edwards BK, Nandakumar A,Ndom P,Capocaccia R,Coleman MP; ICCC-3 Session A
Group. Cancer control-planning and monitoring population-based systems. Tumori 2009;95(5):56878.
92 Formelli F,Meneghini E,Cavadini E,Camerini T, Di Mauro MG, De Palo G,Veronesi U,Berrino
F,Micheli A. Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer
Epidemiol Biomarkers Prev 2009 18(1):42-8.
93 Pierotti MA,Micheli A,Sutcliffe SB. The 3rd International Cancer Control Congress: international
collaboration in an era of cancer as a global concern. Tumori 2009; 95(5):565-7.
94 Micheli A,Di Salvo F,Lombardo C,Ciampichini R,Ugolini D,Baili P,Pierotti MA. Italian
performance in cancer research. Tumori 2009; 95(2):133-41
95 Secreto G, Venturelli E, Meneghini E,Greco M,Ferraris C,Gion M,Zancan M,Fabricio AS,Berrino
F, Cavalleri A; Micheli A. Testosterone and biological characteristics of breast cancers in
postmenopausal women. Cancer Epidemiol Biomarkers Prev 2009;18(11):2942-8.
96 Sant. M, Allemani C, De Angelis R, Carbone A, De Sanjosè S, Gianni A.M, Giraldo P, Marchesi F,
Marcos-Gragera R, Martos-jimenez C, Maynadié M, Raphael M, Berrino F, EUROCARE-3
Working Group.Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the
United States. Eur J Cancer. 2008; 44:579-587.
97 Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C Meningioma Crit Rev in
Oncol/Hemat, 2008; 67. 153-171
98 Coleman M, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B,
Gatta G,Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Francisci
S, SantaquilaniM, Verdecchia A, Storm HH, Young JL, Concord Working Group. Cancer survival
in five continents. A worldwide population-based study (CONCORD). Lancet Onc, 2008 9(8).73056
99 Baili P, Micheli A, De Angelis R, Weir HK, Francisci S, Santaquilani M, Hakulinen T, Quaresmas
M,Coleman MP; CONCORD Working Group. Life tables for world-wide comparison of relative
survival for cancer (CONCORD study). Tumori, 2008;94(5).658-68
100 Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E;
EUROCAREWorking Group. Survival in patients with uveal melanoma in Europe. Arch
Ophthalmol, 2008;126(10).1413-898.
101 Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival
in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncology 2007;8:784-796.
102 Berrino F, De Angelis R, Sant M, Rosso S, Lasota M.B, Coebergh J.W, et al. Survival for eight
majorcancers and all cancers combined for European adults diagnosed in 1995-99: results of the
EUROCARE-4study. Lancet Oncol. 2007 ;8(9):773-83.
103 Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F, et al. Hepatocellular
carcinoma: trendsof incidence and survival in Europe and United States at the end of the 20th
century. Am J Gastroenterol.2007;102:1661-1670.
104 Quaglia A, Capocaccia R, Micheli A, Carrani E, Vercelli M, the EUROCARE-3 Working Group.
A wide difference in cancer survival between middle aged and elderly patients in Europe. Int J
Cancer 2007;120:2196-2201.
105 Sant M, Allemani C, Sieri S, Krogh V, Menard S, Tagliabue E, Nardini E, Micheli A, Crosignani P,
Muti P,Berrino F. Salad vegetables dietary pattern protects against HER-2-positive breast cancer. A
prospectiveItalian study Int J Cancer, 2007;121. 911-914
106 . Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, Forman D, Hedèlin G,
Rachtan J,Lutz JM, Otter R, Raverdy N, Plesko I I, Primic MZ, Tagliabue G. Ten-year survival and
risk of relapse for testicular cancer. a EUROCARE high resolution study.Eur J Cancer, 2007
;43(3).585-92
107 Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M;
EUROCAREWorking group. Survival for eight major cancers and all cancers combined for
European adults diagnosedin 1995-99. results of the EUROCARE-4 study. Lancet Oncol, 2007
;8(9).773-83. Erratum in. Lancet Oncol.2007;8(10).868.
108 Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Time trends of breast
cancersurvival in Europe in relation to incidence and mortality. Int J Cancer. 2006 Nov
15;119(10).2417-22
109 Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Should we use
incidence,survival or mortality to assess breast cancer trends in European women? Nat Clin Pract
Oncol ,2006;3. 228-229
110 Allemani C, Sant M, De Angelis R, Gragera R.M, Coebergh J.W, the Eurocare Working Group.
Hodgkin disease survival in Europe and the U.S. Cancer 2006;107:352-360.
111 Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P,
Danzon A,Federico M, Gafa L, Grosclaude P, Hedelin G, Mace-Lesech J, Garcia CM, Paci E,
Raverdy N, Tretarre B,Williams EM Prognostic value of morphology and hormone receptor status in
breast cancer - a population based study. Br J Cancer, 2004 91. 1263-1268
112 Sant M, Allemani C, Berrino F, Coleman M.P, Aareleid T, et al. Breast carcinoma survival in
Europe andthe United States – A population-based study. Cancer 2004;100:715-722.
113 Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda
T,Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P,
Lisi D.EUROCARE-3. survival of cancer patients diagnosed 1990-94--results and commentary. Ann
Oncol, 2003;14 Suppl 5.v61-118.
114 Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L,
SantaquilaniM, Berrino F and EUROCARE Working Group. EUROCARE-3 summary. cancer
survival in Europe at the end of the 20th century. Ann Oncol, 2003;14 Suppl 5.v128-49.
115 Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh J.W, Coleman M.P,
Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F. Stage at diagnosis is a key explanation of
differences in breast cancer survival across Europe. Int J Cancer 2003;1;106(3):416-22.
116 Forman D, Stockton D, Møller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer prevalence in
theUK: results from the EUROPREVAL study. Ann Oncol. 2003;14:648-654.
117 Micheli A, Yancik R, Krogh V, Verdecchia A, Sant M, Capocaccia R, Berrino F, Ries L. Contrasts
in cancer prevalence in Connecticut, Iowa, and Utah. Cancer 2002; 15;95.430-9.
118 Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza M.I, Paci E. A comparative analysis
of cancer prevalence in cancer registry areas of France; Italy and Spain. Ann Oncol. 2002;13:11281139.
119 Micheli A, Mugno E, Krogh V, Quinn M.J, Coleman M, Hakulinen T, Gatta G, Berrino F,
Capocaccia R.Cancer Prevalence in European Registry Areas. Ann Oncol. 2002;13:840-865.
120 Capocaccia R, Colonna M, Corazzieri I, De Angelis R, Francisci S, Micheli A, Mugno E.
Measuring cancerprevalence in Europe: the EUROPREVAL Project. Ann Oncol. 2002;13:831-839.
121 Sant M and EUROCARE Working Group. Differences in stage and therapy for breast cancer
across Europe. Int J Cancer, 2001; 93.894-901
122 Sant M, Capocaccia R, Coleman M.P, Berrino F, Gatta G, Micheli A, Verdecchia A, et. al. Cancer
survival increases in Europe; but international differences remain wide. Eur J Cancer. 2001;37:16591667.
123 Verdecchia A, Mariotto A, Capocaccia R, Gatta G, Micheli A, Sant M, Berrino F. Incidence and
prevalence of all cancerous diseases in Italy. trends and implications. Eur J Cancer 2001; 37.114957.
124 Sant M, Capocaccia R, Badioni V. Survival for retinoblastoma in Europe. Eur J Cancer.
2001;37:730-735.
125 Berrino F, Gatta G, Sant M, Capocaccia R. The EUROCARE study of survival of cancer patients in
Europe: aims; current status; strengths and weaknesses. Eur J Cancer. 2001;37:673-677.
126 Gatta G, Capocaccia R, Coleman MP, Gloeckler Ries L.A, Hakulinen T, Micheli A, Sant M,
Verdecchia A, and Berrino F. Toward a Comparison of Survival in American and European Cancer
Patients. Cancer 2000;89:893-900.
127 Gatta G, Capocaccia R, Sant M, Bell C.M.J, Coebergh J.W.W, Damhuis R.A.M, Faivre J, MartinezGarciaC, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams E.M.I, Berrino F.
Understanding variationsn survival for colorectal cancer in Europe: a EUROCARE high resolution
study. Gut 2000;47:533-538.
128 Sant M. [Reference data on survival of cancer patients in 17 European countries]. Epidemiol Prev,
2000;24.44-5. (no abs.)
129 Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A.
(editors).Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific
Publication 1999;151.
130 . Gatta G, Capocaccia R, Hakulinen T, Sant M, Verdecchia A, De Angelis G, Micheli A, Berrino F.
Variations in survival for invasive cervical cancer among European women, 1978-89. EUROCARE
Working Group. Cancer Causes Control, 1999;10.575-81.
131 Sant M, Barchielli A, Francisci S, Canario F. The prevalence of tumors of the breast and female
genital tract in Italy. Tumori, 1999; 85.382-6.
132 Zanetti R, Micheli A, Rosso S, Sant M. The prevalence of cancer. a review of the available data.
Tumori,1999; 85.408-13.
133 Sant M, Berrino F, Coebergh JW. . Cancer survival in Britain. Reliable data on stage distribution are
essential. BMJ, 1999; 11;319.1572-3
134 Sant M, van der Sanden G, Capocaccia R. Survival rates for primary malignant brain tumours in
Europe. Eur J Cancer. 1998;34:2241-2247.
135 Aareleid T, Sant M, Hédelin G. Improved survival for patients with testicular cancer in Europe since
1978.Eur J Cancer 1998;34:2236-2240.
136 Faivre J, Forman D, Estève J, Obradovic M, Sant M. Survival of patients with primary liver cancer;
pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer. 1998;34:2184-2190.
137 Coebergh J.W.W, Sant M, Berrino F, Verdecchia A. Survival of Adult Cancer Patients in Europe
Diagnosedfrom 1978-1989: The EUROCARE II Study. Eur J Cancer. 1998;34:2137-2138
138 Sant M. La sopravvivenza per carcinoma mammario. Attualità in senologia, 1998; 19. 5-9.
139 Sant M, Capocaccia R, Verdecchia A, Esteve J, Gatta G, Micheli A, Coleman MP, Berrino F.
Survival of women with breast cancer in Europe. variation with age, year of diagnosis and country.
The EUROCAREWorking Group. Int J Cancer, 1998; 31;77.679-83
140 Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G. The cure for colon
cancer: resultsfrom the Eurocare Study. Int J Cancer 1998;77:322-329.
141 Micheli A, Gatta G, Sant M, Krogh V, Perone C, Dell'Era L, Saltarelli S, Berrino F. Breast cancer
prevalence measured by the Lombardy Cancer Registry. Tumori, 1997; 83.875-9
142 Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori,
1997;83.9-16
143 Capocaccia R, De Angelis R, Frova L, Gatta G, Sant M, Micheli A, Berrino F, Conti E, Gafa L,
Roncucci L,Verdecchia A. Estimation and projections of colorectal cancer trends in Italy. Int J
Epidemiol, 1997; 26.924-32.
144 Sant M, Gatta G, Valente F, Barchielli A, Ramazzotti V, Serventi L, Rosso S. The ITACARE
Study.Tumori, 1997; 83.17-24.
145 144. Gatta G, Sant M, Micheli A, Capocaccia R, Verdecchia A, Barchielli A, Gafa L, Ramazzotti V,
Berrino F.[Survival for digestive system tumors. Italian population-based data and international
comparisons]. Ann Ist Super Sanita, 1996; 32.513-25.
146 Ponz de Leon M, Micheli A, Gatta G, Capocaccia R, Sant M, Gafa L, Conti EM, Roncucci L,
Berrino F.[Survival for tumors of the colon and the rectum in Italy]. Ann Ist Super Sanita, 1996;
32.527-36
147 De Angelis R, Valente F, Frova L, Capocaccia R, Micheli A, Chessa E, Sant M. Incidence,
mortality and prevalence of stomach cancer in Italian regions. Tumori, 1996; 82.314-20.
148 Gatta G, Sant M, Coebergh JW, Hakulinen T. Substantial variation in therapy for colorectal cancer
acrossEurope. EUROCARE analysis of cancer registry data for 1987. Eur J Cancer, 1996; 32A.831-5
149 Gatta G, Sant M. Survival of cancer patients in Europe. Guide to tables. IARC Sci Publ, 1995;132
:75-91.
150 Sant M, Gatta G. The EUROCARE database. IARC Sci Publ, 1995; 132.15-31.
151 Sant M, Gatta G, Barchielli A, Conti EM, Gafa L, Magnani C, Ponz de Leon M. Health care
system, cancer registration and follow-up of cancer patients in Italy. IARC Sci Publ, 1995; 132.60-2.
152 Sant M, Capocaccia R, Verdecchia V, Gatta G, Micheli A, Mariotto A, Hakulinen T, Berrino F,
EUROCARE Working Group. Comparison of colon-cancer survival among european countries:
the EUROCARE study. Int J Cancer 1995;63:43-48.
153 Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, Micheli A, Berrino F, Barchielli
A, Conti E, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes
Control, 1995; 6.339-46.
154 Berrino F, Sant M, Verdecchia V, Capocaccia R, Hakulinen T, Estéve J.(editors). Survival of cancer
patients in Europe: the EUROCARE Study. IARC Scientific Publication 1995;132.